Austen Maniscalco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Austen Maniscalco has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Dan Nguyen
Medical Artificial Intelligence and Automation Laboratory Department of Radiation Oncology University of Texas Southwestern Medical Center Dallas Texas USA
5 shared publications - Steve Jiang
University of Texas Southwestern Medical Center
4 shared publications David Sher
Medical Artificial Intelligence and Automation Laboratory, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States of America
3 shared publications- Biling Wang
Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America
2 shared publications - Chenyang Shen
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
2 shared publications - Sean J. Domal
Department of Radiation Oncology University of Texas Southwestern Medical Center Dallas Texas USA
2 shared publications
Latest Publications
- Open Access
- 8 June 2026
- Published by IOP Publishing in Machine Learning: Health
- Vol. 2 (2) , 025005
Autonomous radiotherapy planning via agentic orchestration using a multimodal TPS-integrated compound AI platform
Autonomous radiotherapy planning via agentic orchestration using a multimodal TPS-integrated compound AI platform, Maniscalco, Austen Matthew, Park, Yang-Kyun, Domal, Sean J, Lin, Mu-Han, Harabagiu, Sanda Maria, Jiang, Steve B, Nguyen, Dan Autonomous radiotherapy planning via agentic orchestration using a multimodal TPS-integrated compound AI platform, Maniscalco, Austen Matthew, Park, Yang-Kyun, Domal, Sean J, Lin, Mu-Han, Harabagiu, Sanda Maria, Jiang, Steve B, Nguyen, Dan
- 8 June 2026
- Published by IOP Publishing in Machine Learning: Health
- Vol. 2 (2) , 025005
Open AccessAutonomous radiotherapy planning via agentic orchestration using a multimodal TPS-integrated compound AI platform
Autonomous radiotherapy planning via agentic orchestration using a multimodal TPS-integrated compound AI platform, Maniscalco, Austen Matthew, Park, Yang-Kyun, Domal, Sean J, Lin, Mu-Han, Harabagiu, Sanda Maria, Jiang, Steve B, Nguyen, Dan Autonomous radiotherapy planning via agentic orchestration using a multimodal TPS-integrated compound AI platform, Maniscalco, Austen Matthew, Park, Yang-Kyun, Domal, Sean J, Lin, Mu-Han, Harabagiu, Sanda Maria, Jiang, Steve B, Nguyen, Dan
- Open Access
- 13 August 2025
- Published by IOP Publishing in Machine Learning: Health
- Vol. 1 (1)
Adaptive Radiotherapy Dose Prediction on Head and Neck Cancer Patients with a 3D Multi-Headed U-Net Deep Learning Architecture
Online adaptive radiation therapy (ART) personalizes treatment plans by accounting for daily anatomical changes, requiring workflows distinct from conventional radiotherapy. Deep learning-based dose prediction models can enhance treatment planning efficiency by rapidly generating accuracy dose distributions, reducing manual trial-and-error and accelerating the overall workflow; however, most existing approaches overlook critical pre-treatment plan information—specifically, physician-defined clinical objectives tailored to individual patients. To address this limitation, we introduce the multi-headed U-Net (MHU-Net), a novel architecture that explicitly incorporates physician intent from pre-treatment plans to improve dose prediction accuracy in adaptive head and neck cancer treatments. Our dataset comprised 43 patients, each with pre-treatment plans, adaptive treatment plans, structure sets, and CT images. MHU-Net builds upon the widely adopted Stander U-Net architecture, extending it with a dual-head design: the primary head processes adaptive session contours and their corresponding signed distance maps, while the secondary head integrates pre-treatment contours, signed distance maps, and dose distributions. The features are merged within a primary U-Net framework to enhance dose prediction accuracy for adaptive treatment sessions. To evaluate the effectiveness of MHU-Net, we conducted a comparative analysis against U-Net. On average, MHU-Net reduced organ-at-risk dose prediction errors, achieving 1.78% lower maximum dose error and 1.22% lower mean dose error compared to U-Net. For the planning target volume, MHU-Net demonstrated significantly improved accuracy, with maximum and mean dose errors of 3.54 ± 2.75% and 1.07 ± 0.88%, respectively, outperforming U-Net’s corresponding errors of 5.36 ± 4.19% and 2.76 ± 2.22% (P < 0.05). Taken together, these findings demonstrate that the proposed MHU-Met advances DL-based dose prediction for ART by effectively integrating both pre-treatment and adaptive session data. This approach facilitates the generation of dose distributions that more closely resemble the clinical ground truth, supporting personalization in ART planning and improving alignment with physician intent and treatment objectives.
- 13 August 2025
- Published by IOP Publishing in Machine Learning: Health
- Vol. 1 (1)
Open AccessAdaptive Radiotherapy Dose Prediction on Head and Neck Cancer Patients with a 3D Multi-Headed U-Net Deep Learning Architecture
Online adaptive radiation therapy (ART) personalizes treatment plans by accounting for daily anatomical changes, requiring workflows distinct from conventional radiotherapy. Deep learning-based dose prediction models can enhance treatment planning efficiency by rapidly generating accuracy dose distributions, reducing manual trial-and-error and accelerating the overall workflow; however, most existing approaches overlook critical pre-treatment plan information—specifically, physician-defined clinical objectives tailored to individual patients. To address this limitation, we introduce the multi-headed U-Net (MHU-Net), a novel architecture that explicitly incorporates physician intent from pre-treatment plans to improve dose prediction accuracy in adaptive head and neck cancer treatments. Our dataset comprised 43 patients, each with pre-treatment plans, adaptive treatment plans, structure sets, and CT images. MHU-Net builds upon the widely adopted Stander U-Net architecture, extending it with a dual-head design: the primary head processes adaptive session contours and their corresponding signed distance maps, while the secondary head integrates pre-treatment contours, signed distance maps, and dose distributions. The features are merged within a primary U-Net framework to enhance dose prediction accuracy for adaptive treatment sessions. To evaluate the effectiveness of MHU-Net, we conducted a comparative analysis against U-Net. On average, MHU-Net reduced organ-at-risk dose prediction errors, achieving 1.78% lower maximum dose error and 1.22% lower mean dose error compared to U-Net. For the planning target volume, MHU-Net demonstrated significantly improved accuracy, with maximum and mean dose errors of 3.54 ± 2.75% and 1.07 ± 0.88%, respectively, outperforming U-Net’s corresponding errors of 5.36 ± 4.19% and 2.76 ± 2.22% (P < 0.05). Taken together, these findings demonstrate that the proposed MHU-Met advances DL-based dose prediction for ART by effectively integrating both pre-treatment and adaptive session data. This approach facilitates the generation of dose distributions that more closely resemble the clinical ground truth, supporting personalization in ART planning and improving alignment with physician intent and treatment objectives.
- Open Access
- 31 July 2025
- Published by IOP Publishing in Machine Learning: Health
- Vol. 1 (1) , 015004
Geometry-encoded deep learning (GeoDL) framework for real-time 3D dose verification for online adaptive radiotherapy
Accurate and efficient dose verification is vital for online adaptive radiotherapy (ART) while the patient is waiting on the treatment couch. Conventional methods are computationally intensive, limiting ART workflow efficiency and quality. A pilot study successfully illustrated the potential of geometry-encoded deep learning (GeoDL) algorithm for two-dimensional (2D) dose estimation on the central axial plane. This study investigates the feasibility of extending GeoDL for real-time dose verification for the entire three-dimensional (3D) volume of interest, fulfilling the unmet need in real clinical practice. The proposed GeoDL unifies the representation of fluence maps (FMs) and CT images by resolving the treatment delivery geometry of a linear accelerator (LINAC) to ease the burden of learning the complex domain transformation between FMs and CT image. A carefully designed 3D U-Net was trained on the integrated CT-FM volume to estimate the 3D dose distribution for the entire volume of interest, utilizing a combined loss function focusing on prediction errors in both high and low dose regions. The model was trained and validated on 281 prostate cancer cases, with 24 additional cases employed for independent testing. The proposed GeoDL algorithm achieved highly accurate 3D dose estimation in almost real-time. The average γ passing rate (, 10% threshold) for the estimated dose was 99.94% ± 0.15% on testing patients. The mean dose differences for the planning target volume (PTV) and organs at risk (OARs) were 0.93% ± 0.59% and 0.28% ± 0.32%, respectively. The average overall computational time for each testing case is ~35ms. This study demonstrates the feasibility of GeoDL in ultra-fast dose verification for ART, with strong performance in relevant dosimetric metrics across the entire volume of interest, positioning it as a valuable tool for real clinical use.- 31 July 2025
- Published by IOP Publishing in Machine Learning: Health
- Vol. 1 (1) , 015004
Open AccessGeometry-encoded deep learning (GeoDL) framework for real-time 3D dose verification for online adaptive radiotherapy
Accurate and efficient dose verification is vital for online adaptive radiotherapy (ART) while the patient is waiting on the treatment couch. Conventional methods are computationally intensive, limiting ART workflow efficiency and quality. A pilot study successfully illustrated the potential of geometry-encoded deep learning (GeoDL) algorithm for two-dimensional (2D) dose estimation on the central axial plane. This study investigates the feasibility of extending GeoDL for real-time dose verification for the entire three-dimensional (3D) volume of interest, fulfilling the unmet need in real clinical practice. The proposed GeoDL unifies the representation of fluence maps (FMs) and CT images by resolving the treatment delivery geometry of a linear accelerator (LINAC) to ease the burden of learning the complex domain transformation between FMs and CT image. A carefully designed 3D U-Net was trained on the integrated CT-FM volume to estimate the 3D dose distribution for the entire volume of interest, utilizing a combined loss function focusing on prediction errors in both high and low dose regions. The model was trained and validated on 281 prostate cancer cases, with 24 additional cases employed for independent testing. The proposed GeoDL algorithm achieved highly accurate 3D dose estimation in almost real-time. The average γ passing rate (, 10% threshold) for the estimated dose was 99.94% ± 0.15% on testing patients. The mean dose differences for the planning target volume (PTV) and organs at risk (OARs) were 0.93% ± 0.59% and 0.28% ± 0.32%, respectively. The average overall computational time for each testing case is ~35ms. This study demonstrates the feasibility of GeoDL in ultra-fast dose verification for ART, with strong performance in relevant dosimetric metrics across the entire volume of interest, positioning it as a valuable tool for real clinical use. - Open Access
- 19 March 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 26 (5) , e70045
Closing the gap in plan quality: Leveraging deep‐learning dose prediction for adaptive radiotherapy
Purpose: Balancing quality and efficiency has been a challenge for online adaptive therapy. Most systems start the online re‐optimization with the original planning goals. While some systems allow planners to modify the planning goals, achieving a high‐quality plan within time constraints remains a common barrier. This study aims to bolster plan quality by leveraging a deep‐learning dose prediction model to predict new planning goals that account for inter‐fractional anatomical changes.Methods: Fine‐tuned patient‐specific (FT‐PS) models were clinically evaluated to accurately predict dose for 23 adaptive fractions of 15 head‐and‐neck (H&N) patients treated with Ethos ART. The original adapted plan from the adaptive treatment session was used as the quality baseline. Based on physician‐approved adaptive treatment contours, the FT‐PS model predicted subsequent planning goals for high‐impact organs at risk (OARs). These goals were retrospectively re‐optimized in Ethos to compare the original adapted plan (IOE‐Auto Plan) with the newly re‐optimized plan (AI‐guided IOE Plan). A physician blindly selected the preferred plan.Results: Dose savings were observed for nine high impact OAR's including the constrictor, ipsilateral/contralateral parotid, ipsilateral/contralateral submandibular gland, oral cavity, and esophagus, mandible and larynx with a maximum value of 5.47 Gy. Of the 23 plans reviewed in the blind observer study, 19 re‐optimized plans were chosen over the original adapted session plan.Conclusions: Our preliminary results demonstrate the feasibility of utilizing an AI dose predictor to predict optimal planning goals with anatomical changes, thereby improving adaptive plan quality. This method is feasible for both online and offline adaptive radiotherapy (ART) and has the potential to significantly enhance treatment outcomes for head‐and‐neck (H&N) cancer patients.
- 19 March 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 26 (5) , e70045
Open AccessClosing the gap in plan quality: Leveraging deep‐learning dose prediction for adaptive radiotherapy
Purpose: Balancing quality and efficiency has been a challenge for online adaptive therapy. Most systems start the online re‐optimization with the original planning goals. While some systems allow planners to modify the planning goals, achieving a high‐quality plan within time constraints remains a common barrier. This study aims to bolster plan quality by leveraging a deep‐learning dose prediction model to predict new planning goals that account for inter‐fractional anatomical changes.Methods: Fine‐tuned patient‐specific (FT‐PS) models were clinically evaluated to accurately predict dose for 23 adaptive fractions of 15 head‐and‐neck (H&N) patients treated with Ethos ART. The original adapted plan from the adaptive treatment session was used as the quality baseline. Based on physician‐approved adaptive treatment contours, the FT‐PS model predicted subsequent planning goals for high‐impact organs at risk (OARs). These goals were retrospectively re‐optimized in Ethos to compare the original adapted plan (IOE‐Auto Plan) with the newly re‐optimized plan (AI‐guided IOE Plan). A physician blindly selected the preferred plan.Results: Dose savings were observed for nine high impact OAR's including the constrictor, ipsilateral/contralateral parotid, ipsilateral/contralateral submandibular gland, oral cavity, and esophagus, mandible and larynx with a maximum value of 5.47 Gy. Of the 23 plans reviewed in the blind observer study, 19 re‐optimized plans were chosen over the original adapted session plan.Conclusions: Our preliminary results demonstrate the feasibility of utilizing an AI dose predictor to predict optimal planning goals with anatomical changes, thereby improving adaptive plan quality. This method is feasible for both online and offline adaptive radiotherapy (ART) and has the potential to significantly enhance treatment outcomes for head‐and‐neck (H&N) cancer patients.
- Open Access
- 14 March 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 26 (5) , e70012
Enhanced dose prediction for head and neck cancer artificial intelligence‐driven radiotherapy based on transfer learning with limited training data
Purpose: Training deep learning dose prediction models for the latest cutting‐edge radiotherapy techniques, such as AI‐based nodal radiotherapy (AINRT) and Daily Adaptive AI‐based nodal radiotherapy (DA‐AINRT), is challenging due to limited data. This study aims to investigate the impact of transfer learning on the predictive performance of an existing clinical dose prediction model and its potential to enhance emerging radiotherapy approaches for head and neck cancer patients.Method: We evaluated the impact and benefits of transfer learning by fine‐tuning a Hierarchically Densely Connected U‐net on both AINRT and DA‐AINRT patient datasets, creating ModelAINRT (Study 1) and ModelDA‐AINRT (Study 2). These models were compared against pretrained and baseline models trained from scratch. In Study 3, both fine‐tuned models were tested using DA‐AINRT patients' final adaptive sessions to assess ModelAINRT ’s effectiveness on DA‐AINRT patients, given that the primary difference is planning target volume (PTV) sizes between AINRT and DA‐AINRT.Result: Studies 1 and 2 revealed that the transfer learning model accurately predicted the mean dose within 0.71% and 0.86% of the prescription dose on the test data. This outperformed the pretrained and baseline models, which showed PTV mean dose prediction errors of 2.29% and 1.1% in Study 1, and 2.38% and 2.86% in Study 2 (P < 0.05). Additionally, Study 3 demonstrated significant improvements in PTV dose prediction error with ModelDA‐AINRT, with a mean dose difference of 0.86% ± 0.73% versus 2.26% ± 1.65% (P < 0.05). This emphasizes the importance of training models for specific patient cohorts to achieve optimal outcomes.Conclusion: Applying transfer learning to dose prediction models significantly improves prediction accuracy for PTV while maintaining similar dose performance in predicting organ‐at‐risk (OAR) dose compared to pretrained and baseline models. This approach enhances dose prediction models for novel radiotherapy methods with limited training data.
- 14 March 2025
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 26 (5) , e70012
Open AccessEnhanced dose prediction for head and neck cancer artificial intelligence‐driven radiotherapy based on transfer learning with limited training data
Purpose: Training deep learning dose prediction models for the latest cutting‐edge radiotherapy techniques, such as AI‐based nodal radiotherapy (AINRT) and Daily Adaptive AI‐based nodal radiotherapy (DA‐AINRT), is challenging due to limited data. This study aims to investigate the impact of transfer learning on the predictive performance of an existing clinical dose prediction model and its potential to enhance emerging radiotherapy approaches for head and neck cancer patients.Method: We evaluated the impact and benefits of transfer learning by fine‐tuning a Hierarchically Densely Connected U‐net on both AINRT and DA‐AINRT patient datasets, creating ModelAINRT (Study 1) and ModelDA‐AINRT (Study 2). These models were compared against pretrained and baseline models trained from scratch. In Study 3, both fine‐tuned models were tested using DA‐AINRT patients' final adaptive sessions to assess ModelAINRT ’s effectiveness on DA‐AINRT patients, given that the primary difference is planning target volume (PTV) sizes between AINRT and DA‐AINRT.Result: Studies 1 and 2 revealed that the transfer learning model accurately predicted the mean dose within 0.71% and 0.86% of the prescription dose on the test data. This outperformed the pretrained and baseline models, which showed PTV mean dose prediction errors of 2.29% and 1.1% in Study 1, and 2.38% and 2.86% in Study 2 (P < 0.05). Additionally, Study 3 demonstrated significant improvements in PTV dose prediction error with ModelDA‐AINRT, with a mean dose difference of 0.86% ± 0.73% versus 2.26% ± 1.65% (P < 0.05). This emphasizes the importance of training models for specific patient cohorts to achieve optimal outcomes.Conclusion: Applying transfer learning to dose prediction models significantly improves prediction accuracy for PTV while maintaining similar dose performance in predicting organ‐at‐risk (OAR) dose compared to pretrained and baseline models. This approach enhances dose prediction models for novel radiotherapy methods with limited training data.
- Open Access
- 11 October 2024
- Published by IOP Publishing in Machine Learning: Science and Technology
- Vol. 5 (4) , 045013
Quality assurance for online adaptive radiotherapy: a secondary dose verification model with geometry-encoded U-Net
In online adaptive radiotherapy (ART), quick computation-based secondary dose verification is crucial for ensuring the quality of ART plans while the patient is positioned on the treatment couch. However, traditional dose verification algorithms are generally time-consuming, reducing the efficiency of ART workflow. This study aims to develop an ultra-fast deep-learning (DL) based secondary dose verification algorithm to accurately estimate dose distributions using computed tomography (CT) and fluence maps (FMs). We integrated FMs into the CT image domain by explicitly resolving the geometry of treatment delivery. For each gantry angle, an FM was constructed based on the optimized multi-leaf collimator apertures and corresponding monitoring units. To effectively encode treatment beam configuration, the constructed FMs were back-projected to 30 cm away from the isocenter with respect to the exact geometry of the treatment machines. Then, a 3D U-Net was utilized to take the integrated CT and FM volume as input to estimate dose. Training and validation were performed on 381 prostate cancer cases, with an additional 40 testing cases for independent evaluation of model performance. The proposed model can estimate dose in ∼ 15 ms for each patient. The average γ passing rate ( 3 % / 2 mm , 10 % threshold) for the estimated dose was 99.9% ± 0.15% on testing patients. The mean dose differences for the planning target volume and organs at risk were 0.07 % ± 0.34 % and 0.48 % ± 0.72 % , respectively. We have developed a geometry-resolved DL framework for accurate dose estimation and demonstrated its potential in real-time online ART doses verification.
- 11 October 2024
- Published by IOP Publishing in Machine Learning: Science and Technology
- Vol. 5 (4) , 045013
Open AccessQuality assurance for online adaptive radiotherapy: a secondary dose verification model with geometry-encoded U-Net
In online adaptive radiotherapy (ART), quick computation-based secondary dose verification is crucial for ensuring the quality of ART plans while the patient is positioned on the treatment couch. However, traditional dose verification algorithms are generally time-consuming, reducing the efficiency of ART workflow. This study aims to develop an ultra-fast deep-learning (DL) based secondary dose verification algorithm to accurately estimate dose distributions using computed tomography (CT) and fluence maps (FMs). We integrated FMs into the CT image domain by explicitly resolving the geometry of treatment delivery. For each gantry angle, an FM was constructed based on the optimized multi-leaf collimator apertures and corresponding monitoring units. To effectively encode treatment beam configuration, the constructed FMs were back-projected to 30 cm away from the isocenter with respect to the exact geometry of the treatment machines. Then, a 3D U-Net was utilized to take the integrated CT and FM volume as input to estimate dose. Training and validation were performed on 381 prostate cancer cases, with an additional 40 testing cases for independent evaluation of model performance. The proposed model can estimate dose in ∼ 15 ms for each patient. The average γ passing rate ( 3 % / 2 mm , 10 % threshold) for the estimated dose was 99.9% ± 0.15% on testing patients. The mean dose differences for the planning target volume and organs at risk were 0.07 % ± 0.34 % and 0.48 % ± 0.72 % , respectively. We have developed a geometry-resolved DL framework for accurate dose estimation and demonstrated its potential in real-time online ART doses verification.